Menu

Filtros : "Financiamento Sichuan Science and Technology Program" "Financiamento CNPq" Limpar

Filtros

Refine with date range

  • 1

1 - 2 (2 records)

  • Artigo de periodico

    Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy (2025)

    Illes, Peter; Rubini, Patrizia; Ulrich, Henning ; Yin, Hai-Yan; Tang, Yong

    Source: MedComm. Unidade: IQ

    Subjects: RECEPTORES, ADENOSINA, TRANSTORNOS COGNITIVOS

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      ILLES, Peter et al. Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy. MedComm, v. 6, p. 1-23 art. e70177, 2025Tradução . . Disponível em: https://dx.doi.org/10.1002/mco2.70177. Acesso em: 16 nov. 2025.

    • APA

      Illes, P., Rubini, P., Ulrich, H., Yin, H. -Y., & Tang, Y. (2025). Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy. MedComm, 6, 1-23 art. e70177. doi:10.1002/mco2.70177

    • NLM

      Illes P, Rubini P, Ulrich H, Yin H-Y, Tang Y. Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy [Internet]. MedComm. 2025 ; 6 1-23 art. e70177.[citado 2025 nov. 16 ] Available from: https://dx.doi.org/10.1002/mco2.70177

    • Vancouver

      Illes P, Rubini P, Ulrich H, Yin H-Y, Tang Y. Dysregulation of astrocytic ATP/adenosine release in the hippocampus cause cognitive and affective disorders: molecular mechanisms, diagnosis, and therapy [Internet]. MedComm. 2025 ; 6 1-23 art. e70177.[citado 2025 nov. 16 ] Available from: https://dx.doi.org/10.1002/mco2.70177

  • Artigo de periodico

    Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies (2023)

    Jia, Wenhui; Huang, Zhao; Zhou, Li; Liou, Yih-Cherng; Virgilio, Francesco Di ; Ulrich, Henning ; Peter, Illes; Zhang, Wei; Huang, Canhua ; Tang, Yong

    Source: Drug Resistance Updates. Unidade: IQ

    Subjects: NEOPLASIAS, PURINAS, PROLIFERAÇÃO CELULAR

    Versão PublicadaAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      JIA, Wenhui et al. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resistance Updates, v. 70, p. 1-13 art. 100988, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.drup.2023.100988. Acesso em: 16 nov. 2025.

    • APA

      Jia, W., Huang, Z., Zhou, L., Liou, Y. -C., Virgilio, F. D., Ulrich, H., et al. (2023). Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies. Drug Resistance Updates, 70, 1-13 art. 100988. doi:10.1016/j.drup.2023.100988

    • NLM

      Jia W, Huang Z, Zhou L, Liou Y-C, Virgilio FD, Ulrich H, Peter I, Zhang W, Huang C, Tang Y. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies [Internet]. Drug Resistance Updates. 2023 ; 70 1-13 art. 100988.[citado 2025 nov. 16 ] Available from: https://doi.org/10.1016/j.drup.2023.100988

    • Vancouver

      Jia W, Huang Z, Zhou L, Liou Y-C, Virgilio FD, Ulrich H, Peter I, Zhang W, Huang C, Tang Y. Purinergic signalling in cancer therapeutic resistance: From mechanisms to targeting strategies [Internet]. Drug Resistance Updates. 2023 ; 70 1-13 art. 100988.[citado 2025 nov. 16 ] Available from: https://doi.org/10.1016/j.drup.2023.100988
  • 1

1 - 2 (2 records)

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2025